Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I Antibody concentrations, avidity and functional activity

Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I Antibody concentrations, avidity and functional activity

<p>Abstract</p> <p><it>Streptococcus pneumoniae </it>is a serious worldwide pathogen and the focus of numerous vaccine development projects. Currently the most widely accepted surrogate marker for evaluating the efficacy of a given vaccine is to utilize ELISA. Measureme...

Full description

Bibliographic Details
Main Authors:	Carlone George M, Romero-Steiner Sandra, Khuder Sadik, Shriner Anne K, Smithson S Louise, Kolibab Kris, Westerink MA Julie
Format:	Article
Language:	English
Published:	BMC 2005-06-01
Series:	Immunity & Ageing
Online Access:	http://www.immunityageing.com/content/2/1/10

Similar Items

Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly
by: Rijkers GT, et al.
Published: (2018-03-01)

Inflammatory Markers and Immune Response to Pneumococcal Vaccination in HIV-Positive and -Negative Adults.
by: Anita S Iyer, et al.
Published: (2016-01-01)

Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine in Brazilian elderly
by: V. Simonsen, et al.
Published: (2005-02-01)

Isolation and Characterization of Human Monoclonal Antibodies to Pneumococcal Capsular Polysaccharide 3
by: Rachelle Babb, et al.
Published: (2021-12-01)

Antibody response to pneumococcal capsular polysaccharide vaccine in Down syndrome patients
by: B.T. Costa-Carvalho, et al.
Published: (2006-12-01)

Multiplexed suspension array immunoassays for detection of antibodies to pneumococcal polysaccharide and conjugate vaccines
by: Sherry A. Dunbar
Published: (2023-11-01)

Antibody enhanced HPLC for serotype-specific quantitation of polysaccharides in pneumococcal conjugate vaccine
by: James Z. Deng, et al.
Published: (2023-01-01)

The role of antibody concentration and avidity in antiviral protection.
by: Bachmann, M, et al.
Published: (1997)

Avidity of antineurocytoskeletal antibodies in Alzheimer's disease patients
by: Libuse Noskova, et al.
Published: (2017-06-01)

Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis.
by: Gerhard Falkenhorst, et al.
Published: (2017-01-01)

Evaluation of acute and convalescent antibody concentration against pneumococcal capsular polysaccharides for the diagnosis of pneumococcal infection in children with community-acquired pneumonia
by: Carter, MJ, et al.
Published: (2024)

ELISA determination of IgG antibodies to pneumococcal capsular polysaccharides in a group of children.
by: Windebank, K, et al.
Published: (1987)

A tool for evaluating heterogeneity in avidity of polyclonal antibodies
by: Li, K, et al.
Published: (2023)

A tool for evaluating heterogeneity in avidity of polyclonal antibodies
by: Kan Li, et al.
Published: (2023-02-01)

Modified ELISA for antibody avidity evaluation: The need for standardization
by: Victor Araujo Correa, et al.
Published: (2021-08-01)

Pneumococcal vaccination in persons living with HIV: Pneumococcal conjugate, polysaccharide or both?
by: Bhavna Dhingra, et al.
Published: (2020-12-01)

Avid made easy : video editing with Avid Free DV and the Avid Xpress family /
by: 320615 Fowler, Jaime
Published: (2005)

Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses
by: Laura Radić, et al.
Published: (2023-04-01)

Serotype-specific and age-dependent generation of pneumococcal polysaccharide-specific memory B-cell and antibody responses to immunization with a pneumococcal conjugate vaccine.
by: Clutterbuck, E, et al.
Published: (2008)

Persistence of antibodies 1 year after sequential administration of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine in adults
by: Beate Schmoele-Thoma, et al.
Published: (2019-03-01)

Solubility, Stability, and Avidity of Recombinant Antibody Fragments Expressed in Microorganisms
by: Tae Hyun Kang, et al.
Published: (2020-09-01)

The effect of age on the response to the pneumococcal polysaccharide vaccine
by: Nahm Moon H, et al.
Published: (2010-03-01)

Diagnosis of invasive pneumococcal disease among children in Kenya with enzyme-linked immunosorbent assay for immunoglobulin G antibodies to pneumococcal surface adhesin A.
by: Scott, J, et al.
Published: (2005)

Avid made easy [compact disc] : video editing with Avid Free DV and the Avid Xpress family /
by: 320615 Fowler, Jaime
Published: (2005)

Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: a systematic review
by: Cornelius Remschmidt, et al.
Published: (2016-11-01)

Vaccine effectiveness of the pneumococcal polysaccharide and conjugated vaccines in elderly and high-risk populations in preventing invasive pneumococcal disease: a systematic search and meta-analysis
by: Melina Gade Sikjær, et al.
Published: (2023-01-01)

Pneumococcal Conjugate Vaccination Followed by Pneumococcal Polysaccharide Vaccination in Lung Transplant Candidates and Recipients
by: Thijs W. Hoffman, MD, et al.
Published: (2020-06-01)

IGA Antibody Induced by Immunization With Pneumococcal Polysaccharides Is a Prognostic Tool in Common Variable Immune Deficiencies
by: Federica Pulvirenti, et al.
Published: (2020-06-01)

A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies
by: Ahmet Ozdilek, et al.
Published: (2021-06-01)

Pneumococcal Antibody Titers
by: Pamella F. Abghari MD, et al.
Published: (2017-02-01)

IgY Antibodies from Birds: A Review on Affinity and Avidity
by: Bianca Lisley Barboza Pacheco, et al.
Published: (2023-10-01)

Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants
by: Sonia Budroni, et al.
Published: (2021-05-01)

Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection
by: Aapo Knuutila, et al.
Published: (2023-12-01)

EPSTEIN-BARR VIRUS INFECTIONS – AVIDITY TEST FOR IgG ANTIBODIES
by: Katja Strašek, et al.
Published: (2001-06-01)

Effects of inoculation route and dose on production and avidity of IgY antibodies
by: Michele Pagliari Oliveira Montini, et al.
Published: (2018-01-01)

Few and far between: how HIV may be evading antibody avidity.
by: Joshua S Klein, et al.
Published: (2010-05-01)

Model-based inference of neutralizing antibody avidities against influenza virus.
by: Janina Linnik, et al.
Published: (2022-01-01)

Effects of Capsular Polysaccharide amount on Pneumococcal-Host interactions.
by: Jiaqi Zhu, et al.
Published: (2023-08-01)

Pneumococcal Polysaccharide Vaccination in Pediatric Inflammatory Bowel Disease
by: Tsega Temtem MD, et al.
Published: (2019-05-01)

Pneumococcal capsular polysaccharide structure predicts serotype prevalence.
by: Daniel M Weinberger, et al.
Published: (2009-06-01)